{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:09:14Z","timestamp":1778922554523,"version":"3.51.4"},"reference-count":92,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["UM1 AI164565"],"award-info":[{"award-number":["UM1 AI164565"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 DA051906"],"award-info":[{"award-number":["R01 DA051906"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 AI176601"],"award-info":[{"award-number":["R01 AI176601"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32 AI055403"],"award-info":[{"award-number":["T32 AI055403"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["UM1 AI164570"],"award-info":[{"award-number":["UM1 AI164570"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 AI183430"],"award-info":[{"award-number":["R01 AI183430"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P01 AI169768"],"award-info":[{"award-number":["P01 AI169768"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 AI174863"],"award-info":[{"award-number":["R01 AI174863"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R61\/R33 DA047037"],"award-info":[{"award-number":["R61\/R33 DA047037"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 AI141009"],"award-info":[{"award-number":["R01 AI141009"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.xcrm.2025.102159","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T10:36:21Z","timestamp":1748860581000},"page":"102159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medications for opioid use disorder shape immune responses during chronic HIV infection"],"prefix":"10.1016","volume":"6","author":[{"given":"Jack A.","family":"Collora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savannah F.","family":"Steinhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy C.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel C.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amare","family":"Eshetu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samana","family":"Zeidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuval","family":"Kluger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra A.","family":"Springer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Chi","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102159_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.xcrm.2025.102159_bib2","unstructured":"Drug Overdose Deaths: Facts and Figures. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates."},{"key":"10.1016\/j.xcrm.2025.102159_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.xcrm.2025.102159_bib4","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","article-title":"Untangling the complexity of opioid receptor function","volume":"43","author":"Valentino","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.xcrm.2025.102159_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106961","article-title":"IUPHAR themed review: Opioid efficacy, bias, and selectivity","volume":"197","author":"Ramos-Gonzalez","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.xcrm.2025.102159_bib6","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain","volume":"89","author":"Le Merrer","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.xcrm.2025.102159_bib7","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2009","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.xcrm.2025.102159_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1360-0443.2008.02455.x","article-title":"Buprenorphine tapering schedule and illicit opioid use","volume":"104","author":"Ling","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.xcrm.2025.102159_bib9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40263-019-00637-z","article-title":"Buprenorphine Treatment for Opioid Use Disorder: An Overview","volume":"33","author":"Shulman","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.xcrm.2025.102159_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","article-title":"Injectable, Sustained-Release Naltrexone for the Treatment of Opioid Dependence: A Randomized, Placebo-Controlled Trial","volume":"63","author":"Comer","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.xcrm.2025.102159_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.549272","article-title":"Reconsidering the Usefulness of Adding Naloxone to Buprenorphine","volume":"11","author":"Blazes","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.xcrm.2025.102159_bib12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(18)31487-9","article-title":"A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study","volume":"392","author":"Miller","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2025.102159_bib13","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1097\/QAD.0000000000002673","article-title":"Preventing HIV outbreaks among people who inject drugs in the United States: plus \u00e7a change, plus \u00e7a m\u00eame chose","volume":"34","author":"Strathdee","year":"2020","journal-title":"Aids"},{"key":"10.1016\/j.xcrm.2025.102159_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1515195","article-title":"HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015","volume":"375","author":"Peters","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102159_bib15","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(21)00391-3","article-title":"The opioid crisis and HIV in the USA: deadly synergies","volume":"397","author":"Hodder","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2025.102159_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis","volume":"345","author":"MacArthur","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.xcrm.2025.102159_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab289","article-title":"A Systematic Review and Meta-Analysis of Studies Evaluating the Effect of Medication Treatment for Opioid Use Disorder on Infectious Disease Outcomes","volume":"8","author":"McNamara","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.xcrm.2025.102159_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/QAI.0000000000001634","article-title":"Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial","volume":"78","author":"Springer","year":"2018","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.xcrm.2025.102159_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038335","article-title":"Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners","volume":"7","author":"Springer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102159_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.xcrm.2025.102159_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010315","article-title":"Expression of Opioid Receptors in Cells of the Immune System","volume":"22","author":"Brejchova","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2025.102159_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-5728(97)00221-X","article-title":"Opiate binding sites in the cellular immune system: expression and regulation","volume":"83","author":"Madden","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.xcrm.2025.102159_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/cimm.1996.0118","article-title":"Differential effects of opioids on the proliferation of a macrophage cell line, Bac 1.2F5","volume":"169","author":"Roy","year":"1996","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.xcrm.2025.102159_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.iy.06.040188.001251","article-title":"Opioid peptides and opioid receptors in cells of the immune system","volume":"6","author":"Sibinga","year":"1988","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102159_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-5793(91)80023-V","article-title":"[3H]morphine binding is enhanced by IL-1-stimulated thymocyte proliferation","volume":"287","author":"Roy","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.xcrm.2025.102159_bib26","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/0014-2999(95)00002-3","article-title":"Murine macrophage cell lines contain mu 3-opiate receptors","volume":"273","author":"Makman","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2025.102159_bib27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/bbrc.1995.1538","article-title":"Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages","volume":"209","author":"Sedqi","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2025.102159_bib28","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1006\/bbrc.1995.2709","article-title":"Mu opioid receptor gene expression in immune cells","volume":"216","author":"Chuang","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2025.102159_bib29","doi-asserted-by":"crossref","first-page":"9316","DOI":"10.1073\/pnas.89.19.9316","article-title":"[D-Ala2]deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells","volume":"89","author":"Stefano","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102159_bib30","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1006\/bbrc.1994.2071","article-title":"Delta opioid receptor gene expression in lymphocytes","volume":"202","author":"Chuang","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2025.102159_bib31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0014-5793(95)00766-3","article-title":"Identification of kappa- and delta-opioid receptor transcripts in immune cells","volume":"369","author":"Gav\u00e9riaux","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.xcrm.2025.102159_bib32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0169-328X(95)00096-B","article-title":"Expression of alternate forms of brain opioid 'orphan' receptor mRNA in activated human peripheral blood lymphocytes and lymphocytic cell lines","volume":"32","author":"Wick","year":"1995","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.xcrm.2025.102159_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0165-5728(97)00101-X","article-title":"Detection of basal levels and induction of delta opioid receptor mRNA in murine splenocytes","volume":"78","author":"Sharp","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.xcrm.2025.102159_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1677\/joe.0.1220161","article-title":"Opioid receptors on cells of the immune system: evidence for delta- and kappa-classes","volume":"122","author":"Carr","year":"1989","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.xcrm.2025.102159_bib35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0022-3565(25)09571-0","article-title":"Antiproliferative effects of delta opioids on highly purified CD4+ and CD8+ murine T cells","volume":"273","author":"Shahabi","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.xcrm.2025.102159_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0922-4106(92)90003-E","article-title":"kappa-Opioid binding sites on a murine lymphoma cell line","volume":"227","author":"Bidlack","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2025.102159_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-5728(92)90073-T","article-title":"Kappa opioid binding sites on the R1.1 murine lymphoma cell line: sensitivity to cations and guanine nucleotides","volume":"41","author":"Lawrence","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.xcrm.2025.102159_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0006-2952(94)00440-W","article-title":"Kappa opioid receptors expressed on three related thymoma cell lines. Differences in receptor-effector coupling","volume":"49","author":"Lawrence","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.xcrm.2025.102159_bib39","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1006\/bbrc.1995.1597","article-title":"Expression of kappa opioid receptors in human and monkey lymphocytes","volume":"209","author":"Chuang","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2025.102159_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0165-5728(95)00116-J","article-title":"Sequence of kappa-opioid receptor cDNA in the R1.1 thymoma cell line","volume":"62","author":"Belkowski","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.xcrm.2025.102159_bib41","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1073\/pnas.92.4.1062","article-title":"Identification of kappa opioid receptors in the immune system by indirect immunofluorescence","volume":"92","author":"Lawrence","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102159_bib42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0022-3565(24)37220-9","article-title":"Detection of kappa opioid receptors on mouse thymocyte phenotypic subpopulations as assessed by flow cytometry","volume":"284","author":"Ignatowski","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.xcrm.2025.102159_bib43","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/CDLI.7.5.719-723.2000","article-title":"Detection and function of opioid receptors on cells from the immune system","volume":"7","author":"Bidlack","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.xcrm.2025.102159_bib44","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11481-020-09959-y","article-title":"Effect of Opioid Use on Immune Activation and HIV Persistence on ART","volume":"15","author":"Azzoni","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.xcrm.2025.102159_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/v15081712","article-title":"Beyond the Syndemic of Opioid Use Disorders and HIV: The Impact of Opioids on Viral Reservoirs","volume":"15","author":"Trunfio","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2025.102159_bib46","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3389\/fimmu.2020.01253","article-title":"Methadone Inhibits Viral Restriction Factors and Facilitates HIV Infection in Macrophages","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102159_bib47","doi-asserted-by":"crossref","first-page":"37622","DOI":"10.1074\/jbc.M301224200","article-title":"Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways","volume":"278","author":"Wang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.102159_bib48","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1172\/JCI113140","article-title":"Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells","volume":"80","author":"Peterson","year":"1987","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102159_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneuroim.2013.07.012","article-title":"\u03bc opioid receptor agonist-selective regulation of interleukin-4 in T lymphocytes","volume":"263","author":"B\u00f6rner","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.xcrm.2025.102159_bib50","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.4049\/jimmunol.1300320","article-title":"Inhibition of NF-\u03baB by opioids in T cells","volume":"191","author":"B\u00f6rner","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102159_bib51","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/0024-3205(87)90601-1","article-title":"Immunosuppressive effects of chronic morphine treatment in mice","volume":"41","author":"Bryant","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.xcrm.2025.102159_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/v15041027","article-title":"The Synthetic Opioid Fentanyl Increases HIV Replication and Chemokine Co-Receptor Expression in Lymphocyte Cell Lines","volume":"15","author":"Madhuravasal Krishnan","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2025.102159_bib53","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s13365-022-01090-3","article-title":"The synthetic opioid fentanyl increases HIV replication and chemokine co-receptor expression in vitro","volume":"28","author":"Kong","year":"2022","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.xcrm.2025.102159_bib54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2013.09.013","article-title":"Effect of chronic morphine administration on circulating T cell population dynamics in rhesus macaques","volume":"265","author":"Cornwell","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.xcrm.2025.102159_bib55","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0006-2952(95)00176-Z","article-title":"Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin","volume":"50","author":"Chao","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.xcrm.2025.102159_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/v13081472","article-title":"Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency","volume":"13","author":"Gornalusse","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2025.102159_bib57","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/v15020415","article-title":"Virally Suppressed People Living with HIV Who Use Opioids Have Diminished Latency Reversal","volume":"15","author":"Basukala","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2025.102159_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1742-6405-11-17","article-title":"The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts","volume":"11","author":"Prottengeier","year":"2014","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.xcrm.2025.102159_bib59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-5728(94)90043-4","article-title":"Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells","volume":"50","author":"Peterson","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.xcrm.2025.102159_bib60","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0162-3109(92)90035-B","article-title":"Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility","volume":"23","author":"Bayer","year":"1992","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.xcrm.2025.102159_bib61","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0028-3908(90)90096-A","article-title":"Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism","volume":"29","author":"Bayer","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.xcrm.2025.102159_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2021.100866","article-title":"Design and implementation of a cohort study of persons living with HIV infection who are initiating medication treatment for opioid use disorder to evaluate HIV-1 persistence","volume":"24","author":"Schultheis","year":"2021","journal-title":"Contemp. Clin. Trials Commun."},{"key":"10.1016\/j.xcrm.2025.102159_bib63","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.immuni.2023.10.002","article-title":"Single-cell epigenetic, transcriptional, and protein profiling of latent and active HIV-1 reservoir revealed that IKZF3 promotes HIV-1 persistence","volume":"56","author":"Wei","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102159_bib64","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.immuni.2022.03.004","article-title":"Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones","volume":"55","author":"Collora","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102159_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz0802","article-title":"Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target","volume":"12","author":"Liu","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102159_bib66","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102159_bib67","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41586-022-05538-8","article-title":"Phenotypic signatures of immune selection in HIV-1 reservoir cells","volume":"614","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102159_bib68","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41590-022-01371-3","article-title":"Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4(+) T cell reservoir","volume":"24","author":"Wu","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102159_bib69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20130301","article-title":"Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids","volume":"211","author":"Ramesh","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2025.102159_bib70","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12977-015-0226-9","article-title":"Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach","volume":"12","author":"Cleret-Buhot","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/j.xcrm.2025.102159_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034561","article-title":"Focused examination of the intestinal lamina propria yields greater molecular insight into mechanisms underlying SIV induced immune dysfunction","volume":"7","author":"Mohan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102159_bib72","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1038\/s41467-020-16159-y","article-title":"Single cell transcriptomics reveals opioid usage evokes widespread suppression of antiviral gene program","volume":"11","author":"Karagiannis","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102159_bib73","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41588-021-00790-6","article-title":"ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis","volume":"53","author":"Granja","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2025.102159_bib74","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-Seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2025.102159_bib75","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102159_bib76","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102159_bib77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2025.102159_bib78","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102159_bib79","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102159_bib80","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/s41592-021-01282-5","article-title":"Single-cell chromatin state analysis with Signac","volume":"18","author":"Stuart","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102159_bib81","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nbt.4091","article-title":"Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors","volume":"36","author":"Haghverdi","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102159_bib82","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102159_bib83","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nmeth.4401","article-title":"chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data","volume":"14","author":"Schep","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102159_bib84","doi-asserted-by":"crossref","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","article-title":"JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles","volume":"50","author":"Castro-Mondragon","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102159_bib85","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2025.102159_bib86","doi-asserted-by":"crossref","unstructured":"Dolgalev, I. (2022). msigdbr: MSigDB Gene Sets for Multiple Organisms in a Tidy Data Format. GitHub.","DOI":"10.32614\/CRAN.package.babelgene"},{"key":"10.1016\/j.xcrm.2025.102159_bib87","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv123","article-title":"Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1","volume":"2","author":"Rosenbloom","year":"2015","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.xcrm.2025.102159_bib88","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41587-021-00927-2","article-title":"Scalable, multimodal profiling of chromatin accessibility, gene expression and protein levels in single cells","volume":"39","author":"Mimitou","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102159_bib89","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1101\/gr.277698.123","article-title":"Integration site-dependent HIV-1 promoter activity shapes host chromatin conformation","volume":"33","author":"Collora","year":"2023","journal-title":"Genome Res."},{"key":"10.1016\/j.xcrm.2025.102159_bib90","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/s41587-023-01716-9","article-title":"SEACells infers transcriptional and epigenomic cellular states from single-cell genomics data","volume":"41","author":"Persad","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102159_bib91","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","article-title":"Clonal replacement of tumor-specific T cells following PD-1 blockade","volume":"25","author":"Yost","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102159_bib92","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the Human Immunology Project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat. Rev. Immunol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125002320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125002320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:20:17Z","timestamp":1778919617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125002320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2666379125002320"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102159","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medications for opioid use disorder shape immune responses during chronic HIV infection","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102159"}}